Is 5-MeO-DMT Legal in Wyoming? (2026)

Instrument

Unlawful use of toxic substances; penalty

Source

https://wyoleg.gov/statutes/compress/title06.pdf

Retrieved

2026-10-31

Fingerprint

38a74e45d509fb38

6-9-203.     Unlawful use of toxic substances; penalty.

     (a) A person commits the offense of unlawful use of a
toxic substance if he inhales or ingests or possesses with the
purpose to inhale or ingest, for the purpose of altering his
mental or physical state, any toxic substance that is not
manufactured for human consumption or inhalation.

     (b)    As used in this section “toxic substance” means:

          (i) Volatile solvents including, but not limited to,
paint thinner, gasoline, correction fluid, felt-tip markers,
nail polish remover and glue;
          (ii) Aerosols containing propellants and solvents
such as toluene including, but not limited to, spray paint,
deodorant, hair products, cooking products and fabric
protectors;

          (iii) Gases including, but not limited to, butane,
refrigerants and organic hydrocarbons not created for human
ingestion, inhalation or injection; and

          (iv) Nitrates including, but not limited to
cyclohexyl nitrate, amyl nitrate and butyl nitrate.

     (c) The provisions of subsection (a) of this section do
not apply to a bona fide institution of higher education
conducting research with human volunteers pursuant to guidelines
adopted by the institution or any federal or state agency.

     (d) A violation of this section is punishable by
imprisonment for not more than six (6) months, a fine of not
more than seven hundred fifty dollars ($750.00), or both.

Instrument

Definitions: controlled substance; counterfeit substance

Source

https://wyoleg.gov/statutes/compress/title35.pdf

Retrieved

2026-10-29

Fingerprint

8bb1771a410fd0cb

(iv)  “Controlled substance” means a drug, substance,
or immediate precursor in schedules I through V of article III;

(v)  “Counterfeit substance” means a controlled

substance which, or the container or labeling of which, without
authorization, bears the trademark, trade name, or other
identifying mark, imprint, number or device, or any likeness
thereof, of a manufacturer, distributor, or dispenser other than
the person who in fact manufactured, distributed, or dispensed
the substance;

Instrument

Schedule I hallucinogenic substances; controlled substance definition

Source

https://wyoleg.gov/statutes/compress/title35.pdf

Retrieved

2026-10-29

Fingerprint

5614ccd07cd8d383

(d)  Hallucinogenic substances.-Unless specifically
excepted or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of
the following hallucinogenic substances, their salts, isomers
and salts of isomers whenever the existence of these salts,
isomers and salts of isomers is possible within the specific
chemical designation (for purposes of this paragraph only, the
term "isomer" includes the optical, position and geometric
isomers):

(i)  4-bromo-2, 5-dimethoxyamphetamine; some trade or

other names:   4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA;

(ii)  2, 5-dimethoxyamphetamine; some trade or other

names:   2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA;

(iii)  4-methoxyamphetamine; some trade or other

names:   4-methoxy-alpha-methylphenethylamine;
paramethoxy-amphetamine; PMA;

(iv)  5-methoxy-3,4-methylenedioxy amphetamine;

(v)  4-methyl-2, 5-dimethoxyamphetamine; some trade

and other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and
“STP”;

(vi)  3,4-methylenedioxy amphetamine;

(vii)  3,4,5-trimethoxy amphetamine;

(viii)  Bufotenine; some trade and other names:

3-(beta-dimethy-laminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine;

(ix)  Diethyltryptamine; some trade and other names:

N,N-diethyltryptamine; DET;

(x)  Dimethyltryptamine; some trade or other names:

DMT;

(xi)  Ibogaine; some trade and other names:

7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole;
tabernanthe iboga;

(xii)  Lysergic acid diethylamide;

(xiii)  Marihuana;

(xiv)  Mescaline;

(xv)  Parahexyl; some  trade or other names;

3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl;

(xvi)  Peyote; meaning all parts of the plant

presently classified botanically as Lophophora Williamsii
Lemaire, whether growing or not, the seeds thereof, any extract
from any part of such plant, and every compound, manufacture,
salts, derivative, mixture, or preparation of such plant, its
seeds or extracts;

(xvii)  N-ethyl-3-piperidyl benzilate;

(xviii)  N-methyl-3-piperidyl benzilate;

(xix)  Psilocybin;

(xx)  Psilocyn;

(xxi)  Tetrahydrocannabinols; naturally occurring or
synthetic equivalents of the substances contained in the plant
or in the resinous extractives of Cannabis, sp. and/or naturally
occurring or synthetic substances, derivatives and their isomers
with similar chemical structure and pharmacological activity
such as the following: delta  1 cis or trans
tetrahydrocannabinol and their optical isomers; delta 6 cis or
trans tetrahydrocannabinol and their optical isomers; delta 8
cis or trans tetrahydrocannabinol and their optical isomers;
delta to the 3, 4 cis or trans tetrahydrocannabinol and its
optical isomers. Since nomenclature of these substances is not
internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
covered;

(xxii)  Ethylamine analog of phencyclidine; some trade

or other names:   N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl)
ethylamine, cyclohexamine, PCE;

(xxiii)  Pyrrolidine analog of phencyclidine; some

trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy,
PHP;

(xxiv)  Thiophene analog of phencyclidine; some trade

or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienyl analog of phencyclidine, TPCP, TCP;

(xxv)  Alpha-ethyltryptamine; some trade or other

names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3-
(2-aminobutyl) indole; --ET; and AET;

(xxvi)  4-Bromo-2,5-dimethoxyphenethylamine; some

trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-
aminoethane; alpha-desmethyl DOB; 2C-B, nexus;

(xxvii)  2,5-Dimethoxy-4-ethylamphetamine; some trade

or other names: DOET;

(xxviii)  3,4-Methylenedioxymethamphetamine (MDMA);

(xxix)  3,4-Methylenedioxy-N-ethylamphetamine (also

known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine,
N-ethyl MDA, MDE, MDEA);

(xxx)  N-hydroxy-3,4-methylenedioxyamphetamine (also

known as N-hydroxy-alpha-methyl-
3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);

(xxxi)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some

other names: TCPy;

(xxxii)  2,5-dimethoxy-4-(n)-propylthiophenethylamine

(other name:  2C-T-7), its optical isomers, salts and salts of
isomers;

(xxxiii)  Alpha-methyltryptamine; (other name: AMT);

(xxxiv)  5-methoxy-N,N-diisopropyltryptamine; (other

name: 5-MeO-DIPT), its isomers, salts and salts of isomers;

(xxxv)  Salvinorin A;

(xxxvi)  3,4-Methylenedioxymethcathinone (other names:

Methylone);

(xxxvii)  3,4–Methylenedioxypyrovalerone (MDPV);

(xxxviii)  4–Methylmethcathinone (other names

Mephedrone);

(xxxix)  3–Methoxymethcathinone;

(xl)  3–Fluoromethcathinone;

(xli)  4–Fluoromethcathinone;

(xlii)  Synthetic cannabinoids as follows:

(A)  (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-

(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
some trade or other names: HU-210;

(B)  Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-

6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-
211;

(C)  Any compound structurally derived from 3-(1-

napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1-
napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or
naphthylideneindene by substitution at the nitrogen atom of the
indole ring, pyrrole ring or 3-position of the indene ring by
alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-
(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl,
whether or not further substituted in the indole ring, pyrrole
ring or indene ring to any extent, and whether or not
substituted in the naphthyl or phenyl ring to any extent;

(D)  Repealed By Laws 2012, Ch. 29, § 2.

(E)  Any compound containing a 2-(3-

hydroxycyclohexyl)phenol structure with substitution at the 5-
position of the phenolic ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not substituted in the cyclohexyl ring to any extent;

(F)  2,3-Dihydro-5-methyl-3-(4-

morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
naphthalenylmethanone; some trade or other names: WIN 55,212-2;

tetramethylcyclopropyl)methanone]; other names: XLR-11;

(G)  [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-

tetramethylcyclopropyl)methanone]; other names: UR-144;

(H)  [(1-pentyl-1H-indol-3-yl)(2,2,3,3-

carboxylic acid; other names: PB-22;

(J)  1-pentyl-8-quinolinyl ester-1H-indole-3-

indole-3-carboxylic acid; other names: 5F-PB-22;

(K)  1-(5-fluoropentyl)-8-quinolinyl ester-1H-

indazole-3-carboxamide; other names: AKB48;

(M)  1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-

fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48;

(N)  N-((3s,5s,7s)-adamantan-1-yl)-1-(5-

(O)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-

fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB-
FUBINACA;

pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA;

(P)  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-

pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA;

(Q)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-

(R)  N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1-

(5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB-
PINACA;

(S)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-

fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB-
PINACA;

(T)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl

ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB–
CHMINACA;

len-1-yl)methanone; other names: THJ–2201;

(U)  [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha

acid 8-quinolinyl ester; other names: BB-22.

(W)  1-(cyclohexylmethyl)-1H-indole-3-carboxylic

(xliii)  2-(2,5-dimethoxy-4-ethylphenyl)ethanamine;

other names: 2C-E;

(xliv)  2-(2,5-dimethoxy-4-methylphenyl)ethanamine;

other names: 2C-D;

(xlv)  2-(4-chloro-2,5-dimethoxyphenyl)ethanamine;

other names: 2C-C;

(xlvi)  2-(4-iodo-2,5-dimethoxyphenyl)ethanamine;

other names: 2C-I;

(xlvii)  2-[4-(ethylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-2;

(xlviii)  2-[4-(isopropylthio)-2,5-

dimethoxyphenyl]ethanamine; other names: 2C-T-4;

(xlix)  2-(2,5-dimethoxyphenyl)ethanamine; other

names: 2C-H;

(l)  2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other

names: 2C-N;

(li)  2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine;

other names: 2C-P;

(lii)  4-bromo-2,5-dimethoxy-N-[(2-

methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe;

(liii)  2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-

methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe;

(liv)  4-iodo-2,5-dimethoxy-N-[(2-

methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe;

(lv)  3,4-methylenedioxy-N-ethylcathinone; (other

names: ethylone).

(iv)  “Controlled substance” means a drug, substance,
or immediate precursor in schedules I through V of article III;

Instrument

Schedule I; hallucinogenic substances

Source

https://wyoleg.gov/statutes/compress/title35.pdf

Retrieved

2026-10-31

Fingerprint

d5403f4476716250

35-7-1014.    Substances included in Schedule I.
     (a) The controlled substances listed in this section are
included in Schedule I. Schedule I shall consist of the drugs
and other substances, by whatever official name, common or usual
name, chemical name or brand name designated, listed in this
section.
(d) Hallucinogenic substances.-Unless specifically
excepted or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of
the following hallucinogenic substances, their salts, isomers
and salts of isomers whenever the existence of these salts,
isomers and salts of isomers is possible within the specific
chemical designation (for purposes of this paragraph only, the
term "isomer" includes the optical, position and geometric
isomers):

          (i) 4-bromo-2, 5-dimethoxyamphetamine; some trade or
other names:   4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA;

          (ii) 2, 5-dimethoxyamphetamine; some trade or other
names:   2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA;

          (iii) 4-methoxyamphetamine; some trade or other
names:   4-methoxy-alpha-methylphenethylamine;
paramethoxy-amphetamine; PMA;

         (iv)    5-methoxy-3,4-methylenedioxy amphetamine;

          (v) 4-methyl-2, 5-dimethoxyamphetamine; some trade
and other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and
“STP”;

         (vi)    3,4-methylenedioxy amphetamine;

         (vii)    3,4,5-trimethoxy amphetamine;

          (viii) Bufotenine; some trade and other names:
3-(beta-dimethy-laminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine;

          (ix) Diethyltryptamine; some trade and other names:
N,N-diethyltryptamine; DET;
         (x)    Dimethyltryptamine; some trade or other names:
DMT;

          (xi) Ibogaine; some trade and other names:
7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole;
tabernanthe iboga;

         (xii)    Lysergic acid diethylamide;

         (xiii)    Marihuana;

         (xiv)    Mescaline;

          (xv) Parahexyl; some trade or other names;
3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl;

          (xvi) Peyote; meaning all parts of the plant
presently classified botanically as Lophophora Williamsii
Lemaire, whether growing or not, the seeds thereof, any extract
from any part of such plant, and every compound, manufacture,
salts, derivative, mixture, or preparation of such plant, its
seeds or extracts;

         (xvii)    N-ethyl-3-piperidyl benzilate;

         (xviii)    N-methyl-3-piperidyl benzilate;

         (xix)    Psilocybin;

         (xx)    Psilocyn;

          (xxi) Tetrahydrocannabinols; naturally occurring or
synthetic equivalents of the substances contained in the plant
or in the resinous extractives of Cannabis, sp. and/or naturally
occurring or synthetic substances, derivatives and their isomers
with similar chemical structure and pharmacological activity
such as the following: delta 1 cis or trans
tetrahydrocannabinol and their optical isomers; delta 6 cis or
trans tetrahydrocannabinol and their optical isomers; delta 8
cis or trans tetrahydrocannabinol and their optical isomers;
delta to the 3, 4 cis or trans tetrahydrocannabinol and its
optical isomers. Since nomenclature of these substances is not
internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
covered;
          (xxii) Ethylamine analog of phencyclidine; some trade
or other names:   N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl)
ethylamine, cyclohexamine, PCE;

          (xxiii) Pyrrolidine analog of phencyclidine; some
trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy,
PHP;

          (xxiv) Thiophene analog of phencyclidine; some trade
or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienyl analog of phencyclidine, TPCP, TCP;

          (xxv) Alpha-ethyltryptamine; some trade or other
names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3-
(2-aminobutyl) indole; --ET; and AET;

          (xxvi) 4-Bromo-2,5-dimethoxyphenethylamine; some
trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-
aminoethane; alpha-desmethyl DOB; 2C-B, nexus;

          (xxvii) 2,5-Dimethoxy-4-ethylamphetamine; some trade
or other names: DOET;

         (xxviii)   3,4-Methylenedioxymethamphetamine (MDMA);

          (xxix) 3,4-Methylenedioxy-N-ethylamphetamine (also
known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine,
N-ethyl MDA, MDE, MDEA);

          (xxx) N-hydroxy-3,4-methylenedioxyamphetamine (also
known as N-hydroxy-alpha-methyl-
3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);

          (xxxi) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some
other names: TCPy;

          (xxxii) 2,5-dimethoxy-4-(n)-propylthiophenethylamine
(other name: 2C-T-7), its optical isomers, salts and salts of
isomers;

         (xxxiii)   Alpha-methyltryptamine; (other name: AMT);

          (xxxiv) 5-methoxy-N,N-diisopropyltryptamine; (other
name: 5-MeO-DIPT), its isomers, salts and salts of isomers;
         (xxxv)       Salvinorin A;

          (xxxvi)     3,4-Methylenedioxymethcathinone (other names:
Methylone);

         (xxxvii)      3,4–Methylenedioxypyrovalerone (MDPV);

          (xxxviii)     4–Methylmethcathinone (other names
Mephedrone);

         (xxxix)      3–Methoxymethcathinone;

         (xl)    3–Fluoromethcathinone;

         (xli)    4–Fluoromethcathinone;

         (xlii)       Synthetic cannabinoids as follows:

               (A) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
some trade or other names: HU-210;

               (B) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-
211;

               (C) Any compound structurally derived from 3-(1-
napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1-
napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or
naphthylideneindene by substitution at the nitrogen atom of the
indole ring, pyrrole ring or 3-position of the indene ring by
alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-
(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl,
whether or not further substituted in the indole ring, pyrrole
ring or indene ring to any extent, and whether or not
substituted in the naphthyl or phenyl ring to any extent;

                (D)    Repealed By Laws 2012, Ch. 29, § 2.

               (E) Any compound containing a 2-(3-
hydroxycyclohexyl)phenol structure with substitution at the 5-
position of the phenolic ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not substituted in the cyclohexyl ring to any extent;
               (F) 2,3-Dihydro-5-methyl-3-(4-
morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
naphthalenylmethanone; some trade or other names: WIN 55,212-2;

               (G) [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone]; other names: XLR-11;

               (H) [(1-pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone]; other names: UR-144;

               (J) 1-pentyl-8-quinolinyl ester-1H-indole-3-
carboxylic acid; other names: PB-22;

               (K) 1-(5-fluoropentyl)-8-quinolinyl ester-1H-
indole-3-carboxylic acid; other names: 5F-PB-22;

               (M) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-
indazole-3-carboxamide; other names: AKB48;

               (N) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-
fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48;

               (O) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB-
FUBINACA;

               (P) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA;

               (Q) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA;

               (R) N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1-
(5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB-
PINACA;

               (S) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-
fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB-
PINACA;

               (T) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl
ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB–
CHMINACA;

               (U) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha
len-1-yl)methanone; other names: THJ–2201;
               (W) 1-(cyclohexylmethyl)-1H-indole-3-carboxylic
acid 8-quinolinyl ester; other names: BB-22.

          (xliii) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine;
other names: 2C-E;

          (xliv) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine;
other names: 2C-D;

          (xlv) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine;
other names: 2C-C;

          (xlvi) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine;
other names: 2C-I;

          (xlvii) 2-[4-(ethylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-2;

          (xlviii) 2-[4-(isopropylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-4;

          (xlix)   2-(2,5-dimethoxyphenyl)ethanamine; other
names: 2C-H;

          (l)   2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other
names: 2C-N;

          (li) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine;
other names: 2C-P;

          (lii) 4-bromo-2,5-dimethoxy-N-[(2-
methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe;

          (liii) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe;

          (liv) 4-iodo-2,5-dimethoxy-N-[(2-
methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe;

          (lv) 3,4-methylenedioxy-N-ethylcathinone; (other
names: ethylone).

Instrument

Schedule III; depressants

Source

https://wyoleg.gov/statutes/compress/title35.pdf

Retrieved

2026-10-31

Fingerprint

4a14bd76c15a0d38

35-7-1018.   Substances included in Schedule III.

     (a) The controlled substances listed in this section are
included in Schedule III. Schedule III shall consist of the
drugs and other substances by whatever official name, common or
usual name, chemical name or brand name designated, listed in
this section.
(c) Depressants.-Unless specifically excepted or listed in
another schedule, any material, compound, mixture or preparation
which contains any quantity of the following substances having a
depressant effect on the central nervous system:

          (i) Any compound, mixture or preparation containing
any of the following or any salt thereof, and one (1) or more
other active medicinal ingredient not listed in any schedule:

                (A)    Amobarbital;

                (B)    Secobarbital;

                (C)    Pentobarbital.

          (ii) Any suppository dosage form containing any of
the following or any salt thereof, and approved by the food and
drug administration for marketing only as a suppository:

                (A)    Amobarbital;

                (B)    Secobarbital;

                (C)    Pentobarbital.

          (iii) Any substance which contains any quantity of a
derivative of barbituric acid or any salt thereof;

         (iv)    Chorhexadol;

         (v)    Repealed By Laws 1997, ch. 151, § 2.

         (vi)    Lysergic acid;

         (vii)    Lysergic acid amide;

         (viii)       Methyprylon;

         (ix)    Sulfondiethylmethane;

         (x)    Sulfonethylmethane;

         (xi)    Sulfonmethane;

          (xii) Tiletamine and zolazepam or any salt thereof;
some trade or other names for a tiletamine-zolazepam combination
product: telazol; some trade or other names for tiletamine: 2-
(ethylamino)-2-(2-thienyl)-cyclohexanone; some trade or other
names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-
trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
flupyrazapon;

          (xiii) Ketamine, its salts, isomers and salts of
isomers (some other names for ketamine include (±)-2-(2-
chlorophenyl)-2-(methylamino)-cyclohexanone);

          (xiv) Any drug product containing gamma hydoxybutyric
acid, its salts, isomers and salts of isomers, for which an
application is approved under section 505 of the federal Food,
Drug and Cosmetic Act.

Instrument

Schedule I, hallucinogenic substances

Source

https://wyoleg.gov/statutes/compress/title35.pdf

Retrieved

2026-10-28

Fingerprint

c00df93bcbc014a1

(d)  Hallucinogenic substances.-Unless specifically
excepted or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of
the following hallucinogenic substances, their salts, isomers
and salts of isomers whenever the existence of these salts,
isomers and salts of isomers is possible within the specific
chemical designation (for purposes of this paragraph only, the
term "isomer" includes the optical, position and geometric
isomers):

(i)  4-bromo-2, 5-dimethoxyamphetamine; some trade or

other names:   4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA;

(ii)  2, 5-dimethoxyamphetamine; some trade or other

names:   2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA;

(iii)  4-methoxyamphetamine; some trade or other

names:   4-methoxy-alpha-methylphenethylamine;
paramethoxy-amphetamine; PMA;

(iv)  5-methoxy-3,4-methylenedioxy amphetamine;

(v)  4-methyl-2, 5-dimethoxyamphetamine; some trade

and other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and
“STP”;

(vi)  3,4-methylenedioxy amphetamine;

(vii)  3,4,5-trimethoxy amphetamine;

(viii)  Bufotenine; some trade and other names:

3-(beta-dimethy-laminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine;

(ix)  Diethyltryptamine; some trade and other names:

N,N-diethyltryptamine; DET;

(x)  Dimethyltryptamine; some trade or other names:

DMT;

(xi)  Ibogaine; some trade and other names:

7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole;
tabernanthe iboga;

(xii)  Lysergic acid diethylamide;

(xiii)  Marihuana;

(xiv)  Mescaline;

(xv)  Parahexyl; some  trade or other names;

3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl;

(xvi)  Peyote; meaning all parts of the plant

presently classified botanically as Lophophora Williamsii
Lemaire, whether growing or not, the seeds thereof, any extract
from any part of such plant, and every compound, manufacture,
salts, derivative, mixture, or preparation of such plant, its
seeds or extracts;

(xvii)  N-ethyl-3-piperidyl benzilate;

(xviii)  N-methyl-3-piperidyl benzilate;

(xix)  Psilocybin;

(xx)  Psilocyn;

(xxi)  Tetrahydrocannabinols; naturally occurring or
synthetic equivalents of the substances contained in the plant
or in the resinous extractives of Cannabis, sp. and/or naturally
occurring or synthetic substances, derivatives and their isomers
with similar chemical structure and pharmacological activity
such as the following: delta  1 cis or trans
tetrahydrocannabinol and their optical isomers; delta 6 cis or
trans tetrahydrocannabinol and their optical isomers; delta 8
cis or trans tetrahydrocannabinol and their optical isomers;
delta to the 3, 4 cis or trans tetrahydrocannabinol and its
optical isomers. Since nomenclature of these substances is not
internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
covered;

(xxii)  Ethylamine analog of phencyclidine; some trade

or other names:   N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl)
ethylamine, cyclohexamine, PCE;

(xxiii)  Pyrrolidine analog of phencyclidine; some

trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy,
PHP;

(xxiv)  Thiophene analog of phencyclidine; some trade

or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienyl analog of phencyclidine, TPCP, TCP;

(xxv)  Alpha-ethyltryptamine; some trade or other

names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3-
(2-aminobutyl) indole; --ET; and AET;

(xxvi)  4-Bromo-2,5-dimethoxyphenethylamine; some

trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-
aminoethane; alpha-desmethyl DOB; 2C-B, nexus;

(xxvii)  2,5-Dimethoxy-4-ethylamphetamine; some trade

or other names: DOET;

(xxviii)  3,4-Methylenedioxymethamphetamine (MDMA);

(xxix)  3,4-Methylenedioxy-N-ethylamphetamine (also

known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine,
N-ethyl MDA, MDE, MDEA);

(xxx)  N-hydroxy-3,4-methylenedioxyamphetamine (also

known as N-hydroxy-alpha-methyl-
3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);

(xxxi)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some

other names: TCPy;

(xxxii)  2,5-dimethoxy-4-(n)-propylthiophenethylamine

(other name:  2C-T-7), its optical isomers, salts and salts of
isomers;

(xxxiii)  Alpha-methyltryptamine; (other name: AMT);

(xxxiv)  5-methoxy-N,N-diisopropyltryptamine; (other

name: 5-MeO-DIPT), its isomers, salts and salts of isomers;

(xxxv)  Salvinorin A;

(xxxvi)  3,4-Methylenedioxymethcathinone (other names:

Methylone);

(xxxvii)  3,4–Methylenedioxypyrovalerone (MDPV);

(xxxviii)  4–Methylmethcathinone (other names

Mephedrone);

(xxxix)  3–Methoxymethcathinone;

(xl)  3–Fluoromethcathinone;

(xli)  4–Fluoromethcathinone;

(xlii)  Synthetic cannabinoids as follows:

(A)  (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-

(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
some trade or other names: HU-210;

(B)  Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-

6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-
211;

(C)  Any compound structurally derived from 3-(1-

napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1-
napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or
naphthylideneindene by substitution at the nitrogen atom of the
indole ring, pyrrole ring or 3-position of the indene ring by
alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-
(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl,
whether or not further substituted in the indole ring, pyrrole
ring or indene ring to any extent, and whether or not
substituted in the naphthyl or phenyl ring to any extent;

(D)  Repealed By Laws 2012, Ch. 29, § 2.

(E)  Any compound containing a 2-(3-

hydroxycyclohexyl)phenol structure with substitution at the 5-
position of the phenolic ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not substituted in the cyclohexyl ring to any extent;

(F)  2,3-Dihydro-5-methyl-3-(4-

morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
naphthalenylmethanone; some trade or other names: WIN 55,212-2;

tetramethylcyclopropyl)methanone]; other names: XLR-11;

(G)  [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-

tetramethylcyclopropyl)methanone]; other names: UR-144;

(H)  [(1-pentyl-1H-indol-3-yl)(2,2,3,3-

carboxylic acid; other names: PB-22;

(J)  1-pentyl-8-quinolinyl ester-1H-indole-3-

indole-3-carboxylic acid; other names: 5F-PB-22;

(K)  1-(5-fluoropentyl)-8-quinolinyl ester-1H-

indazole-3-carboxamide; other names: AKB48;

(M)  1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-

fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48;

(N)  N-((3s,5s,7s)-adamantan-1-yl)-1-(5-

(O)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-

fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB-
FUBINACA;

pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA;

(P)  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-

pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA;

(Q)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-

(R)  N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1-

(5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB-
PINACA;

(S)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-

fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB-
PINACA;

(T)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl

ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB–
CHMINACA;

len-1-yl)methanone; other names: THJ–2201;

(U)  [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha

acid 8-quinolinyl ester; other names: BB-22.

(W)  1-(cyclohexylmethyl)-1H-indole-3-carboxylic

(xliii)  2-(2,5-dimethoxy-4-ethylphenyl)ethanamine;

other names: 2C-E;

(xliv)  2-(2,5-dimethoxy-4-methylphenyl)ethanamine;

other names: 2C-D;

(xlv)  2-(4-chloro-2,5-dimethoxyphenyl)ethanamine;

other names: 2C-C;

(xlvi)  2-(4-iodo-2,5-dimethoxyphenyl)ethanamine;

other names: 2C-I;

(xlvii)  2-[4-(ethylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-2;

(xlviii)  2-[4-(isopropylthio)-2,5-

dimethoxyphenyl]ethanamine; other names: 2C-T-4;

(xlix)  2-(2,5-dimethoxyphenyl)ethanamine; other

names: 2C-H;

(l)  2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other

names: 2C-N;

(li)  2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine;

other names: 2C-P;

(lii)  4-bromo-2,5-dimethoxy-N-[(2-

methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe;

(liii)  2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-

methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe;

(liv)  4-iodo-2,5-dimethoxy-N-[(2-

methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe;

(lv)  3,4-methylenedioxy-N-ethylcathinone; (other

names: ethylone).